ResMed (RMD)
(Delayed Data from NYSE)
$218.57 USD
-1.40 (-0.64%)
Updated May 17, 2024 04:00 PM ET
After-Market: $218.56 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 521 - 526 ( 526 total )
Company: ResMed Inc.
Industry: Medical - Products
Survey data and currency movements suggest modest Q4 upside
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
UnitedHealthcare: Go home, use APAP - New coverage policy positive for ResMed
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
BiancaMed acquisition smart move, despite near-term dilution
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Acquires BiancaMed and new AASM sleep testing legislative effort.
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Wake Up - skip the snooze button with a STRONG BUY, $40.40 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B